NASDAQ:SINTSintx Technologies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sintx Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.01 +0.20 (+11.05 %) (As of 07/13/2020 04:00 PM ET) Add Compare Share Today's Range$1.70Now: $2.01▼$2.0750-Day Range$0.68MA: $1.22▼$2.2852-Week Range$0.28Now: $2.01▼$4.39Volume9.58 million shsAverage Volume4.09 million shsMarket Capitalization$38.95 millionP/E RatioN/ADividend YieldN/ABeta1.62 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInstitutional OwnershipHeadlinesSocial Media Sintx Technologies, Inc., a biomaterial company, researches, develops, manufactures, and commercializes a range of medical implant products manufactured with silicon nitride in the United States, Europe, and South America. The company offers ceramic based biomaterial solutions in various medical and industrial applications. It provides spine implant products under the Valeo brand to surgeons and hospitals for use in cervical and thoracolumbar spine surgery. The company markets and sells its products directly; and through direct sales organizations, distributors, as well as original equipment manufacturer and private label partnerships. Sintx Technologies, Inc. has a collaboration agreement with CTL Amedica to design and launch spinal implants. The company was formerly known as Amedica Corporation and changed its name to Sintx Technologies, Inc. in October 2018. Sintx Technologies, Inc. was founded in 1996 and is headquartered in Salt Lake City, Utah.Read More Beat the Market (BTM) Rank™ 2.3 Analyst's Opinion Consensus RatingSintx Technologies has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.25, Sintx Technologies has a potential upside of 11.9% from its current price of $2.01.Amount of Analyst CoverageSintx Technologies has only been the subject of 2 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesSintx Technologies has received 33 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSintx Technologies has received 32 “underperform” votes. (Add your “underperform” vote.)Community SentimentSintx Technologies has received 50.77% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Sintx Technologies and other stocks. Vote “Outperform” if you believe SINT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SINT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSintx Technologies does not currently pay a dividend.Dividend GrowthSintx Technologies does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sintx Technologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.29% of the stock of Sintx Technologies is held by insiders.Percentage Held by InstitutionsOnly 0.91% of the stock of Sintx Technologies is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Sintx Technologies is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sintx Technologies is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSintx Technologies has a P/B Ratio of 0.94. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.08 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SINT Previous Symbol CUSIPN/A CIKN/A Webwww.sintx.com Phone801-839-3500Debt Debt-to-Equity Ratio0.16 Current Ratio4.65 Quick Ratio4.56Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$690,000.00 Price / Sales56.45 Cash FlowN/A Price / Cash FlowN/A Book Value$2.14 per share Price / Book0.94Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-4,800,000.00 Net Margins-250.19% Return on Equity-27.69% Return on Assets-17.24%Miscellaneous Employees19 Outstanding Shares19,379,000Market Cap$38.95 million Next Earnings Date8/20/2020 (Estimated) OptionableNot Optionable NASDAQ:SINT Rates by TradingView Receive SINT News and Ratings via Email Sign-up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter. Sintx Technologies (NASDAQ:SINT) Frequently Asked Questions How has Sintx Technologies' stock been impacted by COVID-19 (Coronavirus)? Sintx Technologies' stock was trading at $0.41 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SINT shares have increased by 390.2% and is now trading at $2.01. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Sintx Technologies? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sintx Technologies in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Sintx Technologies. When is Sintx Technologies' next earnings date? Sintx Technologies is scheduled to release its next quarterly earnings announcement on Thursday, August 20th 2020. View our earnings forecast for Sintx Technologies. How were Sintx Technologies' earnings last quarter? Sintx Technologies (NASDAQ:SINT) released its quarterly earnings results on Wednesday, May, 13th. The company reported ($1.35) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.18) by $1.17. The firm had revenue of $0.21 million for the quarter. Sintx Technologies had a negative return on equity of 27.69% and a negative net margin of 250.19%. View Sintx Technologies' earnings history. What price target have analysts set for SINT? 2 brokerages have issued 1-year price targets for Sintx Technologies' stock. Their forecasts range from $2.25 to $2.25. On average, they anticipate Sintx Technologies' stock price to reach $2.25 in the next twelve months. This suggests a possible upside of 11.9% from the stock's current price. View analysts' price targets for Sintx Technologies. Has Sintx Technologies been receiving favorable news coverage? News stories about SINT stock have trended very negative recently, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sintx Technologies earned a coverage optimism score of -3.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about Sintx Technologies. Who are some of Sintx Technologies' key competitors? Some companies that are related to Sintx Technologies include TELA Bio (TELA), Lyra Therapeutics (LYRA), Soliton (SOLY), Restoration Robotics (HAIR), BeyondAirInc . (XAIR), Venus Concept (VERO), PAVmed (PAVM), Spectral Medical (EDTXF), SANUWAVE Health (SNWV), AIT Therapeutics (AITB), Nephros (NEPH), Pro-Dex (PDEX), Nephros (NEPHD), BRAINSWAY LTD/S (BWAY) and Titan Medical (TMDI). View all competitors. What other stocks do shareholders of Sintx Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sintx Technologies investors own include Gilead Sciences (GILD), AT&T (T), Carnival (CCL), General Electric (GE), General Motors (GM), IBM (IBM), Kohl's (KSS), NovaBay Pharmaceuticals (NBY), Nokia Oyj (NOK) and Occidental Petroleum (OXY). Who are Sintx Technologies' key executives? Sintx Technologies' management team includes the following people: Dr. B. Sonny Bal, Chairman, Pres, CEO & Principal Financial Officer (Age 57)Mr. Bryan J. McEntire, Chief Scientific Officer (Age 67)Mr. David O'brien, Chief Operating Officer (Age 54) What is Sintx Technologies' stock symbol? Sintx Technologies trades on the NASDAQ under the ticker symbol "SINT." How do I buy shares of Sintx Technologies? Shares of SINT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Sintx Technologies' stock price today? One share of SINT stock can currently be purchased for approximately $2.01. How big of a company is Sintx Technologies? Sintx Technologies has a market capitalization of $38.95 million and generates $690,000.00 in revenue each year. Sintx Technologies employs 19 workers across the globe. What is Sintx Technologies' official website? The official website for Sintx Technologies is www.sintx.com. How can I contact Sintx Technologies? Sintx Technologies' mailing address is 1885 West 2100 South, Salt Lake City UT, 84119. The company can be reached via phone at 801-839-3500 or via email at [email protected] This page was last updated on 7/13/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
